Cyclacel Pharmaceuticals, Inc. (CYCC) Covered Calls

Cyclacel Pharmaceuticals, Inc. is a development-stage biopharmaceutical company dedicated to the development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious diseases.

There are no covered calls available for Cyclacel Pharmaceuticals, Inc..

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being conducted under an SPA with the FDA as front-line treatment for acute myeloid leukemia in the elderly, and other studies for myelodysplastic syndromes, chronic lymphocytic leukemia and solid tumors, including breast, lung, ovarian and pancreatic cancer and in particular those carrying BRCA mutations. The company's strategy is to build a diversified biopharmaceutical business focused in hematology and oncology based on a development pipeline of novel drug candidates. Cyclacel Pharmaceuticals was founded by Ronald J. Berenson, David P. Lane and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Top 10 Open Interest For May 17 Expiration				Top 5 High Yield
1.	IWM covered calls	6.	EEM covered calls	1.	BYND covered calls
2.	QQQ covered calls	7.	TSLA covered calls	2.	HIMS covered calls
3.	HYG covered calls	8.	SLV covered calls	3.	BYON covered calls
4.	SPY covered calls	9.	TLT covered calls	4.	UPST covered calls
5.	FXI covered calls	10.	AMZN covered calls	5.	RIVN covered calls

Want more examples? CYBR Covered Calls | CYD Covered Calls